| 영문 | adverse effect | 한글 | 역효과, 유해효과 |
|---|---|---|---|
| 설명 | 약물에 의한 치료를 할 때 나타나는 치료목적에 부합되지 않는 불쾌한 작용, 즉 부작용을 역효과로 표현하는 경우가 있다. 세계보건기구(WHO)에서는 역효과란 “예방, 진단, 치료의 목적으로 사람에게 상용량의 약을 사용하였을 때 발현하는 장애로, 의도하지 않은 작용”이라고 정의하고 있다. 약물에 의한 치료를 할 때, 특히 주목하여야 할 일반적인 역효과로서 약물알레르기, 조혈장기 장애, 간-콩팥의 장애, 물질 대사 장애 등이 있다. 이 외에 임산부에게 투여하여 발생한 기형발생, 마약, 각성제, 기타 향정신제에 의한 의존성 형성도 중요하다. |
||
| IUCD | Intra-Uterine Contraceptive Devices; 자궁내 피임 장치 = IUD |
|---|---|
| CDRH | Center for Devices and Radiological Health |
| MDMU | medical devices for military use |
| SMDA | Safe Medical Devices Act [of 1990]; starch methylenedianiline |
| ADE | acute disseminated encephalitis; adverse drug event; antibody-dependent enhancement; apparent digest... |
| OA | Ophthalmic Artery |
|---|---|
| SOV | superior ophthalmic vein |
| CDRH | Center for Devices and Radiological Health |
| CVAD | Central venous access devices |
| SCD | Sequential Compression Devices |
| adverse | Harmful. (18 Nov 1997) |
|---|---|
| adverse drug reaction reporting systems | Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions. (12 Dec 1998) |
| adverse effect | This is an abnormal or harmful effect to an organism caused by exposure to a chemical. It is indicated by some result such as death, a change in food or water consumption, altered body and organ weights, altered enzyme levels, or visible illness. An effect may be classed as adverse if it causes functional or anatomical damage, causes irreversible change in the homeostasis of the organism, or increases the susceptibility of the organism to other chemical or biological stress. A non-adverse effect will usually be reversed when the organism is no longer being exposed to the chemical. (09 Oct 1997) |
| adverse event | A toxic reaction to a medical therapy. (09 Oct 1997) |
| adverse reaction | Any undesirable or unwanted consequence of a preventive, diagnostic, or therapeutic procedure or regimen. (05 Mar 2000) |
| no-observed-adverse-effect level | The highest dosage administered that does not produce toxic effects. The noael will depend on how closely dosages are spaced (lowest-observed-adverse-effect level and no-observed-effect level) and the number of animals examined. The ultimate objective is usually to determine not the "safe" dosage in laboratory animals but the "safe" dosage for humans. Therefore, the extrapolation most often required of toxicologists is from high-dosage studies in laboratory animals to low doses in humans. (casarett and doull's toxicology: the basic science of poisons, 4th ed) (12 Dec 1998) |
| event, adverse | In pharmacology, an adverse event is any unexpected or dangerous reaction to a drug. (12 Dec 1998) |
| meningeal branch of ophthalmic nerve | <anatomy, nerve> See: tentorial nerve. (05 Mar 2000) |
| superior ophthalmic vein | <anatomy, vein> Begins anteriorly from the nasofrontal vein, passes along the upper part of the medial wall of the orbit, passes through the superior orbital fissure, to empty into the cavernous sinus. Synonym: vena ophthalmica superior. (05 Mar 2000) |
| inferior ophthalmic vein | <anatomy, vein> Arises from the inferior palpebral and lacrimal veins and divides into two terminal branches, one of which runs to the pterygoid plexus while the other joins the superior ophthalmic vein or empties into the cavernous sinus. Synonym: vena ophthalmica inferior. (05 Mar 2000) |
| ophthalmic | <anatomy> Pertaining to the eye. (18 Nov 1997) |
| ophthalmic acid | A tripeptide occurring in lens, similar to glutathione but differing in the replacement of cysteine by alpha-amino-n-butyric acid (i.e., in the replacement of -SH by -CH3); a potent inhibitor of glyoxalase. Compare: norophthalmic acid. (05 Mar 2000) |
| ophthalmic artery | <anatomy, artery> Artery originating from the internal carotid artery and distributing to the eye, orbit and adjacent facial structures. (12 Dec 1998) |
| ophthalmic assistants | Persons academically trained to care for patients with eye diseases or structural defects of the eye, under the supervision of an ophthalmologist. (12 Dec 1998) |
| ophthalmic hyperthyroidism | Same as Basedow's disease. Origin: So called after Dr. Graves, of Dublin. Source: Websters Dictionary (01 Mar 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|